Clin Pain.  2020 Jun;19(1):32-35. 10.35827/cp.2020.19.1.32.

Treatment-Induced Neuropathy of Diabetes

• Kim KH
• Leem MJ
• Yi TI
• Kim JS
• Yoon SY

• KMID: 2503497
• DOI: http://doi.org/10.35827/cp.2020.19.1.32

Abstract

Treatment-induced neuropathy in diabetes (TIND) is a reversible neuropathy that occurs in patients with diabetes, usually after a fast improvement in glycemic control. TIND is defined as the sudden onset of neuropathic pain or autonomic dysfunction with a large improvement in glycemic control (glycated hemoglobin [HbA1c] level of ≥ 2% over 3 months). We report the first case of a 24-year-old woman with type 1 diabetes mellitus who developed TIND in Korea. Her HbA1c level had decreased from 16.7% to 7.3% within a 3-month period. She developed acute-onset, severe, and continuous burning pain affecting her back and lower extremities. She was administered tapentadol (50 mg), pregabalin (75 mg), and vitamin B with minerals twice daily for neuropathic pain. She complained of orthostatic hypotension; thus, midodrine (2.5 mg) and anti-embolic stockings were prescribed. She almost completely recovered 6 months after the onset. A physician should be aware of TIND and gradually reduce HbA1c levels to prevent the occurrence of TIDN. They must also try to provide relief from severe pain or autonomic dysfunction and emphasize on an almost complete recovery.

Keyword

Diabetes mellitus; Neuropathy; Autonomic dysfunction; Neuropathic pain; Orthostatic hypotension